内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

2021 老年2型糖尿病管理专家共识——糖尿病和衰弱

2021-05-12 国外内分泌相关专家小组（统称） Diabetes Ther. 2021 May;12(5):1227-1247.

糖尿病

老年糖尿病患者的预后和适当治疗目标因虚衰弱度不同有很大差异，本文主要讨论了老年糖尿病患者可用的降糖策略，本根据患者的衰弱程度提出简单的血糖管理流程。

中文标题：

2021 老年2型糖尿病管理专家共识——糖尿病和衰弱

英文标题：

Diabetes and Frailty: An Expert Consensus Statement on the Management of Older Adults with Type 2 Diabetes

发布机构：

国外内分泌相关专家小组（统称）

发布日期：

2021-05-12

简要介绍：

老年糖尿病患者的预后和适当治疗目标因虚衰弱度不同有很大差异，本文主要讨论了老年糖尿病患者可用的降糖策略，本根据患者的衰弱程度提出简单的血糖管理流程。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 老年2型糖尿病管理专家共识——糖尿病和衰弱.pdf)] GetToolGuiderByIdResponse(projectId=1, id=4be331c00213e577, title=2021 老年2型糖尿病管理专家共识——糖尿病和衰弱, enTitle=Diabetes and Frailty: An Expert Consensus Statement on the Management of Older Adults with Type 2 Diabetes, guiderFrom=Diabetes Ther. 2021 May;12(5):1227-1247., authorId=0, author=, summary=老年糖尿病患者的预后和适当治疗目标因虚衰弱度不同有很大差异，本文主要讨论了老年糖尿病患者可用的降糖策略，本根据患者的衰弱程度提出简单的血糖管理流程。, cover=https://img.medsci.cn/2021726/1627229815472_2020535.jpg, journalId=0, articlesId=null, associationId=949, associationName=国外内分泌相关专家小组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Wed May 12 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>老年糖尿病患者的预后和适当治疗目标因虚衰弱度不同有很大差异，本文主要讨论了老年糖尿病患者可用的降糖策略，本根据患者的衰弱程度提出简单的血糖管理流程。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=216, tagName=糖尿病)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=216, guiderKeyword=糖尿病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7377, appHits=770, showAppHits=0, pcHits=793, showPcHits=6606, likes=6, shares=33, comments=52, approvalStatus=1, publishedTime=Mon Jul 26 00:50:28 CST 2021, publishedTimeString=2021-05-12, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon Jul 26 00:17:03 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 13:07:53 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 老年2型糖尿病管理专家共识——糖尿病和衰弱.pdf)])
2021 老年2型糖尿病管理专家共识——糖尿病和衰弱.pdf
下载请点击：
评论区 (43)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1222572, encodeId=4afd12225e276, content=特别有用的资料 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12cb5438026, createdName=ms4000000901131801, createdTime=Thu May 26 11:22:39 CST 2022, time=2022-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198492, encodeId=ad91119849278, content=求翻译成中文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae5b6530282, createdName=ms6000000425452816, createdTime=Tue Mar 01 21:20:47 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198616, encodeId=2f1511986164c, content=学习了，很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd15015596, createdName=1937600869, createdTime=Wed Mar 02 09:56:16 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193690, encodeId=cc6711936907c, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Tue Feb 15 18:18:34 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192191, encodeId=78e1119219155, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abca5684584, createdName=ms7000000419195392, createdTime=Fri Feb 11 08:57:02 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2022-05-26 ms4000000901131801

    特别有用的资料 学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1222572, encodeId=4afd12225e276, content=特别有用的资料 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12cb5438026, createdName=ms4000000901131801, createdTime=Thu May 26 11:22:39 CST 2022, time=2022-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198492, encodeId=ad91119849278, content=求翻译成中文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae5b6530282, createdName=ms6000000425452816, createdTime=Tue Mar 01 21:20:47 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198616, encodeId=2f1511986164c, content=学习了，很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd15015596, createdName=1937600869, createdTime=Wed Mar 02 09:56:16 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193690, encodeId=cc6711936907c, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Tue Feb 15 18:18:34 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192191, encodeId=78e1119219155, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abca5684584, createdName=ms7000000419195392, createdTime=Fri Feb 11 08:57:02 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2022-03-01 ms6000000425452816

    求翻译成中文

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1222572, encodeId=4afd12225e276, content=特别有用的资料 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12cb5438026, createdName=ms4000000901131801, createdTime=Thu May 26 11:22:39 CST 2022, time=2022-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198492, encodeId=ad91119849278, content=求翻译成中文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae5b6530282, createdName=ms6000000425452816, createdTime=Tue Mar 01 21:20:47 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198616, encodeId=2f1511986164c, content=学习了，很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd15015596, createdName=1937600869, createdTime=Wed Mar 02 09:56:16 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193690, encodeId=cc6711936907c, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Tue Feb 15 18:18:34 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192191, encodeId=78e1119219155, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abca5684584, createdName=ms7000000419195392, createdTime=Fri Feb 11 08:57:02 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2022-03-02 1937600869

    学习了，很好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1222572, encodeId=4afd12225e276, content=特别有用的资料 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12cb5438026, createdName=ms4000000901131801, createdTime=Thu May 26 11:22:39 CST 2022, time=2022-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198492, encodeId=ad91119849278, content=求翻译成中文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae5b6530282, createdName=ms6000000425452816, createdTime=Tue Mar 01 21:20:47 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198616, encodeId=2f1511986164c, content=学习了，很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd15015596, createdName=1937600869, createdTime=Wed Mar 02 09:56:16 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193690, encodeId=cc6711936907c, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Tue Feb 15 18:18:34 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192191, encodeId=78e1119219155, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abca5684584, createdName=ms7000000419195392, createdTime=Fri Feb 11 08:57:02 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2022-02-15 1351fc2f66m

    学习一下

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1222572, encodeId=4afd12225e276, content=特别有用的资料 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12cb5438026, createdName=ms4000000901131801, createdTime=Thu May 26 11:22:39 CST 2022, time=2022-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198492, encodeId=ad91119849278, content=求翻译成中文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae5b6530282, createdName=ms6000000425452816, createdTime=Tue Mar 01 21:20:47 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198616, encodeId=2f1511986164c, content=学习了，很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd15015596, createdName=1937600869, createdTime=Wed Mar 02 09:56:16 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193690, encodeId=cc6711936907c, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Tue Feb 15 18:18:34 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192191, encodeId=78e1119219155, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abca5684584, createdName=ms7000000419195392, createdTime=Fri Feb 11 08:57:02 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2022-02-11 ms7000000419195392

    学习

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

中国养老机构居民血糖标准管理临床专家共识（2021版）

中国老年协会内分泌代谢病学组 · 2021-07-07

基层糖尿病微血管病变筛查与防治专家共识（2021年版）

中国微循环学会(CMS,Chinese Society of Microcirculation) 糖尿病与微循环专业委员会 · 2021-06-17

2021 AIOM_AMD_SIE_SIF多学科共识意见：新发糖尿病胰腺癌的早期预测

意大利肿瘤医学协会(AIOM,Italian Association of Medical Oncology) · 2021-05-18

互联网医院糖尿病线上管理中国专家共识

中国老年保健协会 · 2021-05-19

SGLT-2抑制剂和GLP-1激动剂对成人2型糖尿病临床实践指南

暂未更新 · 2021-05-13

成人糖尿病患者血压管理专家共识

上海市医学会(ShangHai Medical Association) · 2021-02-04

拓展阅读

2009 中国糖尿病护理及教育指南

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2009-10-30

2010CARI 2型糖尿病患者的肾功能评估

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010CARI 2型糖尿病患者中慢性肾脏病的预防和管理

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010 AOA（POA）糖尿病患者眼部健康

美国视觉协会(AOA,American Optometric Association) · 2010-01-01

中国糖尿病医学营养治疗指南 （2010年）

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2010-01-01

运动与2型糖尿病联合声明

美国糖尿病学会(ADA,American Diabetes Association) · 2010-01-01